Renal Resistivity Index as a predictor of acute kidney injury recovery in patient in liver ICU: a prospective observational study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 118
- 试验地点
- 1
- 主要终点
- To study the use of renal resistive index to predict the recovery of patients with acute kidney injury in cirrhotic patients in Liver ICU.
研究概览
简要总结
This is a prospective single arm observational study designed with 118 patients, of male and female genders, to investigate whether the Renal Resistive Index measured in a patient admitted to Liver ICU with acute kidney injury can predict the recovery of the same through the course of treatment.
The Renal Resistive Index or RRI is a value derived from the ultrasound guided imaging of the arteries supplying the kidneys. This value was found to be increased in patients with acute kidney injury with the levels reducing with the recovery of the kidney injury.
In this study, the RRI value will be measured at the time of admission to ICU and the same will be followed up on day 1 through 3 of treatment.
Other values and inputs such as the laboratory investigations of creatinine, volume status such as IVC measurement, Vti, biomarker levels such as NGAL will also be followed up during the course of treatment (Day 1 through 3).
Other details such as need for renal replacement therapy, mechanical ventilation, days of ICU and hospital stay, 30 and 90 day mortality will also be followed up.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients with cirrhosis admitted to Liver ICU with acute kidney injury Male and female patients Age less then 70 Age more than 18.
排除标准
- •Patients with chronic kidney disease Patient refusal.
结局指标
主要结局
To study the use of renal resistive index to predict the recovery of patients with acute kidney injury in cirrhotic patients in Liver ICU.
时间窗: Day of admission | Day 1 to 3 of treatment
次要结局
- 1.To study use of NGAL to predict AKI recovery in Liver ICU(2.To study use of volume markers to predict AKI recovery in Liver ICU.)
研究者
Sharika Sriramanan
Dr Rela Institute and Medical Centre
